Cancer Cures May Already Exist — But Won't Reach Patients If Pelosi's Drug Bill Passes
By Peter J. Pitts
House Democrats recently unveiled H.R. 3, a proposal that would impose ill-considered price controls on prescription drugs.
Patient advocates immediately panned the bill, warning that it would deter medical research and prevent scientists from developing future treatments and cures.
They're right -- but they're understating the bill's harmful effects. The legislation could stifle ongoing "post-approval" research into existing treatments that are already on the market. It would prevent scientists from refining current drug formulas to make them safer or testing medicines in broader patient populations.
In other words, cures for certain types of cancer and other chronic conditions may already exist -- but they won't reach patients if H.R. 3 becomes law.
Consider how the drug development process works. When scientists discover a promising compound, they conduct years of lab tests and animal studies. The majority of potential medicines fail in this pre-clinical trial phase -- only one in 1,000 compounds shows enough promise to merit further testing.
Scientists typically conduct "phase I" clinical trials on healthy humans to confirm a medicine's safety. If the compound proves broadly safe, scientists move on to "phase II" trials in dozens or hundreds of sick patients.
More typically, the FDA requires researchers to prove a drug's safety and efficacy in "phase III" trials, which usually involve hundreds or thousands of sick patients. Drug companies then submit their testing data to the FDA for review.
This process takes a decade or more and it's fraught with failure. Only 12 percent of experimental medicines that enter phase I trials ultimately win FDA approval. After accounting for this high failure rate, it costs $2.6 billion, on average, to bring a new medicine to market.
The research process doesn't end there. Companies often conduct extensive post-approval trials to monitor patients for long term effects.
Innovators also test whether their medicines can effectively treat other, related diseases. Consider the drug Lynparza, which the FDA approved in 2017 to treat certain types of ovarian, fallopian tube, and primary peritoneal cancers. The manufacturer conducted post-approval research, which led to the FDA approving Lynparza for certain forms of breast cancer.
Follow-on research isn't cheap. It adds $300 million, on average, to the drug's R&D cost.
H.R. 3 would discourage such research. The bill imposes steep penalties on companies that raise a medicine's price faster than inflation. The legislation would prevent companies from updating their prices -- even if the new indication is highly valued by patients and the healthcare system.
If the House bill makes it harder to recoup the cost of follow-on research, companies won't make those investments in the first place. Why bother looking for new uses if these post-approval discoveries won't deliver a financial return?
But what makes the policy even less defensible is that it would do nothing to reduce patients' actual pharmacy bills. The proceeds from the inflation penalty would go directly into the government's coffers.
Simply put, patients would lose out on valuable medical discoveries, while deriving no benefits in return. That's not what Americans had in mind when they demanded drug-pricing reform.
Peter J. Pitts, a former FDA Associate Commissioner, is president of the Center for Medicine in the Public Interest.
More Resources
Unable to open RSS Feed $XMLfilename with error HTTP ERROR: 404, exiting
More Medicine Information:
Related Articles
Over The Counter Pain Medication: How To Choose The Right Drugs
With the recent front-page news about the possible hazards of pain medications, you may be taking a look at your over-the-counter (or OTC) pain medications with a wary eye. While all drugs, including those you don't need a prescription for, can be dangerous, some basic knowledge can help you avoid the pitfalls for the pain relief you need.
Hidden ER Costs Undermine Health Markets
Imagine you're traveling in a different state when, suddenly, you begin to feel severe abdominal pain. Being unfamiliar with the area and wanting to avoid hefty out-of-network bills, you call your insurance company to find an in-network hospital.
Benign Tumors Of The Cervix
Endocervical polypsEndocervical polyps are the most common benign neoplasms of the cervix. Please note that the word neoplasm refers to a cancerous growth.
Top Five FAQs About Nail Fungus
What is nail fungus?Nail fungus, also known as Onychomycosis, is an organism which digests the keratin found in your fingernails and toenails. The fingernail and toenail are naturally built to be strong barriers, and resistant to fungi and other infections.
Medical Tourism Opportunities in India
More and more people have started travelling to India for Medical Treatment and during the past year alone, over 150000 people travelled to India for their medical requirements. Medical Tourism is finally coming of age.
The Truth about C Reactive Protein and Cholesterol Lowering Drugs
You might disagree, but hear me out on this..
A Compelling Look at Pain Relief
If your back aches when you're loading groceries in the car or your hands cramp up with arthritis when you sit down at the computer, you're not alone. Although the nature, cause, and complaints vary, over one-half of Americans experience chronic or recurrent pain, a recent survey conducted by the Stanford University Medical Center found.
Toenail Fungus: Treatment and Prevention
A thick, yellowish nail with splotchy white areas is a classic presentation for a fungal toenail. In the early stages the toenail is only slightly discolored, or slightly thickened.
Traditional Treatments for Back Pain... Which Ones Work and Which Ones Don't?
When Dorothy followed the yellow brick road, she was told to do so by those who wanted her to get where she wanted go. Well as humans when we blindly follow recommendations even by individuals who have good intentions, it may not always be your best option.
Bee Propolis: Synergisitc Health Care for the 21st Centruy
For well over a century modern science has progressed at a startling rate. With this increase in knowledge has come medicinal and healthcare benefits that have seen ages peak and diseases eradicated.
Mind Altering
"It's a chemical imbalance." I've heard those words so many times in the last decade, it's becoming routine for Doctors to blame everything on it.
Kids and Medication Part I
We have all talked a lot about the problems in our educational system, about latchkey kids, about teacher turnover (50 percent of teachers quitted within the first five years on the job), psychologists over prescribing medications such as Prozac and Ritalin with our friends and families. We can all foresee a terrible problem in the future because we are feeding these drugs to kids under the age of six, their brains have not been fully formed yet and these drugs and their predecessors and competing drugs all have adverse side effects.
Serevent Side Effects Put Serevent in Top 5 Most Dangerous Drugs
Serevent is an asthma inhalation medication, a bronchodilator, that relaxes the muscles in airways. It is preventative and not effective when taken during an asthma attack.
The Power of Ice
Using ice to treat injuries is one of the oldest methods of pain control. Proven to be safe and effective at reducing swelling, relieving pain and decreasing muscle spasms, ice therapy is an easy self-care technique that anyone can administer.
What Not to Tell Your Doctor?
For many years since medicine has been established as anethical profession and gained widespread credence peoplehave believed that they could and should tell their doctoreverything even remotely pertinent to their health and thatit was held in the strictest confidence. Furthermore, howcan the physician make accurate judgments when important orsignificant information is missing? This system worked verywell until relatively recently but there now exists a breachof this confidence that people should know about and thisbreach has developed from the advent of third partyinvestigations into people's backgrounds.
Bextra and Vioxx Withdrawal Spawn Advertising Pause from Bristol Myers
Pharmaceutical giant Bristol Myers Squibb has announced that they will suspend direct-to-consumer advertising for their prescription drug products for a year. This comes in the wake of the well-publicized withdrawals of Merck's Vioxx and Pfizer's Bextra, two non-steroidal anti-inflammatory drugs (NSAIDs) that were voluntarily withdrawn from the market recently.
Protopic Cancer Risk Lawyer
The FDA issued a warning in July of 2005 on two skin creams, Elidel (pimecrolimus) and Protopic (tacrolimus) to all ages. Recent animal studies have found that Protopic causes lymphomas and skin cancers in an unknown percentage of users.
Melatonin, Sleep Enhancement, and ADHD
OverviewMelatonin is a natural hormone, which is produced and secreted by the pineal gland. Melatonin plays an important role in the regulation of many hormones in the body.
Bulk Forming Drugstore Laxatives
There are five basic types of drugstore laxatives you should be aware of. Some of these laxatives can be dangerous to use.
Sinusitis: Sinus Infection Deals a Corporate KO
Sinusitis and Sinus Infection Starts with a Little SniffleYes, I hear it too. A simple sniffle in a distant cubical.
Cetyl Myristoleate for Arthrtis: Science or Speculation
There are a lot of fabulous stories about Cetyl Myristoleate (also known as CMO or CM) floating across the Internet. Mine is one of them.